APA (7th ed.) Citation

Brynte, C., Aeschlimann, M., Barta, C., Begeman, A. H. A., Bäcker, A., Crunelle, C. L., . . . Franck, J. (2022). The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: Protocol and clinical characteristics of the INCAS study. BMC psychiatry, 22(1), . https://doi.org/10.1186/s12888-022-04259-6

Chicago Style (17th ed.) Citation

Brynte, Christoffer, et al. "The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study." BMC Psychiatry 22, no. 1 (2022). https://doi.org/10.1186/s12888-022-04259-6.

MLA (9th ed.) Citation

Brynte, Christoffer, et al. "The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study." BMC Psychiatry, vol. 22, no. 1, 2022, https://doi.org/10.1186/s12888-022-04259-6.